Adam Levy Sells Shares of NEXGEL, Inc. $NXGL

Key Points

  • Adam Levy sold 5,000 shares of NEXGEL, Inc. ($NXGL) worth $2,950.
  • $NXGL last traded around $0.56.

Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.

Adam Levy, Chief Executive Officer at NEXGEL, Inc. ($NXGL), sold 5,000 shares at an average price of $0.59, for a total transaction of $2,950. The trade was disclosed in a Form 4 filing with the Securities and Exchange Commission.

NEXGEL, Inc. Stock Up 58.7%

Shares of NEXGEL, Inc. ($NXGL) traded around $0.56 on Wednesday, up 58.7% for the day.

Last price$0.56
Market cap$3.50M
Forward P/E-1.63
Beta0.77
52-week low$0.30
52-week high$2.89
50-day MA$0.45
200-day MA$0.94
Current ratio0.43
Quick ratio0.11
Debt-to-equity1.36

NEXGEL, Inc. Earnings

EPS (ttm)-$0.74
Revenue (ttm)$12.07M
Revenue growth27.80%
Net margin-51.26%
Return on equity-115.06%
Next earningsNov 10, 2026

Analysts Set New Price Targets

ConsensusHold

About NEXGEL, Inc.

NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It operates through two segments: Nexgel and CG labs. The company offers over-the-counter remedy solutions, such as blister and pain applications; and beauty and cosmetic solutions. It also develops NEXDrape, an incise surgical drape designed for patients with impaired skin; and NEXDerm, an adhesive tape designed to secure central lines and intravenous tubes and devices to patients before, during, and after medical treatment. In addition, the company engages in the converting and packaging business. It serves its customers under Medagel, Kenkoderm and Silly George brand names. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was incorporated in 2009 and is based in Langhorne, Pennsylvania.

ExchangeNasdaqCM
SectorHealthcare
IndustryMedical Instruments & Supplies
HeadquartersLanghorne, PA
CEOMr. Gregory J. Robb
Employees19

Get NEXGEL, Inc. alerts

New 13F filings, insider trades, and analyst moves on $NXGL, sent to your inbox. Free, and you can unsubscribe anytime.

This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.